HLA class I gene expression on human primary tumours and autologous metastases: Demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

British Journal of Cancer

Volumn 59, Issue 2, 1989, Pages 221-226

  Lopez Nevot M A ^a   Esteban, F ^a   Ferron A ^a   Gutierrez J ^a   Oliva, M R ^a   Romero, C ^a   Huelin, C ^a   Ruiz Cabello, F ^a   Garrido, F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; COLORECTAL CARCINOMA; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; LARYNX CARCINOMA; METASTASIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH CARCINOMA;

BLOTTING, SOUTHERN; COLORECTAL NEOPLASMS; GENES, MHC CLASS I; HLA ANTIGENS; HLA-B ANTIGENS; HUMAN; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; STOMACH NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0024510022     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1989.45     Document Type: Article

References (49)

1. ALBINO, A.P., LLOYD, K.O., HOUGHTON, A N., OETTGEN, H.F. & OLD, L.L.J. (1981). Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. J. Exp. Med., 154, 1764.
2. ANGELINI, G., FOSSATI, G., RADICE, P. & 5 others (1986). Loss of polymorphic restriction fragments of class I and class II MHC genes in a malignant melanoma. J. Immunogenol., 13, 241.
3. BAR ELI, M., BATTIFORA, H. & CLINE, M.J. (1988). Alterations of class I HLA genes in human colon cancers. Human Genetics, 78, 86.
4. BARNSTABLE, C.J., BODMER, W.F., BROWN, G. & 4 others (1978). A production of monoclonal antibodies to group A erythrocytes, HLA and other human cell membrane antigens. New tools for genetic analysis. Cell, 14, 9.
5. BLIN, N. & STAFFORD, D.W. (1976). Isolation of high molecular-weight DNA. Nucleic Acids Res., 3, 2303.
6. BONAL, F.J., PAREJA, E., MARTIN, J., ROMERO, C. & GARRIDO, F. (1986). Repression of class I H-2K, H-2D antigens on GR9 methylcholantrene induced tumour cell clones is related to the level of DNA methylation. J. Immunogen., 13, 179.
7. BOYUM, A. (1968). Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest., 21, Suppl. 97, 77.
8. BRÖCKER, E.B., SUTER, L., BRÜGGEN, J., RUITER, D.J., MACHER, E. & SORG, C. (1985). Phenotypic dynamics of tumour progression in human malignant melanoma. Int. J. Cancer, 36, 29.
9. BURRONE, O.R., KREFFORD, R.F., GILMORE, D. & MILSTEIN, C. (1985). Stimulation of HLA-A, B, C by IFN. The derivation of Molt 4 variants and the differential expression of HLA, B, C subsets. EMBO J., 4, 2855.
10. CORDELL, J.L., FALINI, B., ERBER, W.N. & 6 others (1984). Immunoenzymatic labeling of monoclonal antibodies using immunocomplexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cyto. chem., 32, 219.
11. CULLEN, S.E., DAVID, C.S., SCHREFFLER, D.C. & NATHENSON, S.G. (1974). Membrane molecules determined by the H-2 associated immune response region: isolation and same properties. Proc. Natl Acad. Sci. USA, 71, 648.
12. DAAR, A S., FUGGLE, S.V., FABRE, J.V., TING, A. & MORRIS, P.J. (1984). The detailed distribution of HLA ABC antigens in normal human organs. Transplantation, 38, 287.
13. DAUSSET, J. (1981). The major histocompatibility complex in man. Past, present and future concepts. Science, 213, 1469.
14. DOYLE, A., MARTIN, V.J., FNA, K. & 8 others (1985). Markedly decreased expression of class I histocompatibility antigen, protein and mRNA in human small-cell lung cancer. J. Exp. Med., 161, 1135.
15. EISENBACH, L., FELDMAN, M. & SEGAL, S. (1983). MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int. J. Cancer, 32, 113.
16. EISENBACH, L., HOLLANDER, N., SEGAL, S. & FELDMAN, M. (1985). The differential expression of class I major histocompatibility complex antigens controls the metastatic properties of tumour cells. Transplantation Proc., 27, 729.
17. ENGLEMAN, E.G., CHARRON, D.J., BENIKE, C.J. & STEWART, G.J. (1980). Ia antigen on peripheral blood mononuclear leukocytes in man. Expression biosynthesis and function of HLA-DR antigen on non-T-cells. J. Exp. Med., 152, 99s.
18. FENTESTEIN, H. (1987). The biological consequences of altered MHC expression on tumours. Br. Med. Bull., 43, 217.
19. FENTESTEIN, H. & GARRIDO, F. (1986). MHC antigens and malignancy. Nature, 332, 502.
20. FENTESTEIN, H. & SCHMIDT, V. (1981). Variations in MHC antigen profiles of tumour cells and its biological effects. Immunol. Rev., 60, 85.
21. GARRIDO, F. (1988). H-2 Gene Complex: Genes, Molecules, Functions. C. David: Bar Harbor, Maine.
22. GARRIDO, F., FENTESTEIN, H. & SCHIRMACHER, V. (1976a). Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines. Nature, 261, 705.
23. GARRIDO, F., PÉREZ, M. & TORRES, M.D. (1979). Absence of four H-2d antigenic specificities in an H-2d sarcoma. J. Immunogen., 6, 83.
24. GARRIDO, F., SCHIRMACHER, V. & FENTESTEIN, H. (1976b). H-2-like specificities of foreign haplotypes appearing on a mouse sarcoma after Vaccinia virus infection. Nature, 259, 228.
25. GORER, P.A., LYMAN, S. & SNELL, G.D. (1948). Studies on the genetic basis on tumour transplantation. Linkage between an histocompatibility gene and fused in mice. Proc. Roy. Soc. B, 135, 499.
26. GMÜR, R., SOLTER, D. & KNOWLES, B.B. (1980). Independent regulation of H-2K and H-2D gene expression in murine terato-carcinoma somatic cell hybrids. J. Exp. Med., 151, 1349.
27. GUTIÉRREZ, J., LÓPEZ-NEVOT, M.A., CABRERE, T. & 4 others (1987). Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness. Exp. Clin. Immunogen., 4, 144.
28. KÄRRE, K., LJUNGREN, H.G., PIONTEK, G. & KIESSLING, R. (1986). Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature, 319, 675.
29. KLEIN, J. (1986). Natural History of the Major Histocompatibility Complex. Wiley: New York.
30. 2-microglobulin on human neuroblastoma cell lines. J. Immunol., 13, 2471.
31. LJUNGREN, H.G. & KÄRRE, K. (1986). Experimental strategies and interpretations in the analysis of changes in MHC gene expression during tumour progression. J. Immunogen., 13, 141.
32. LÓPEZ-NEVOT, M.A., GARCÍA, E., PAREJA, E. & 5 others (1986). Differential expression of HLA class I and II antigens in primary and metastatic melanomas. J. Immunogen., 13, 219.
33. MASUCCI, M.G., TORSTEINDOTTIR, S., COLOMBANI, J., BROUTBOR, C., KLEIN, E. & KLEIN, G. (1988). Down regulation of class I HLA antigens and of the Epstein-Barr virus (EBV) encoded latent membrane protein (LMP) in Burkitt lymphoma lines. Proc. Natl Acad. Sci. USA (in the press).
34. MERUELO, D., KORNREICH, R., ROSSOMANDO, A. & 9 Others (1986). Lack of class I H-2 antigens in cells transformed by radiation leukemia virus is associated with methylation and rearrangement of H-2 DNA. Proc. Natl Acad. Sci. USA, 83, 4504.
35. MÖLLER, P., HERRMANN, B., MOLDENHAUER, G. & MOMBURG, F. (1987). Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy. Int. J. Cancer, 40, 32.
36. MORBURG, F., DEGENER, T., BACCHUS, E., MOLDENHANER, G., HÄMMERLING, G. & MÖLLER, P. (1986). Loss of HLA ABC and de novo expression of HLA DR in colorectal cancer. Int. J. Cancer, 37, 179.
37. NATALI, P.G., GIACOMINI, A. & BIGOTTI, A. (1983). Heterogeneity in the expression of HLA and tumour associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res., 43, 660.
38. ORGAD, S., YANG, S.Y., GAZIT, E. & 4 others (1985). Expression of extra class I major histocompatibility antigens on T-cell acute lymphoblastic leukemia (ALL) lymphoblasts. Hum. Immunol., 12, 133.
39. PÉREZ, M., CABRERA, T., LÓPEZ-NEVOT, M.A., GÓMEZ, M., RUIZ-CABELLO, F. & GARRIDO, F. (1986). Heterogeneity of the expression of class I and II antigens in human breast carcinoma. J. Immunogen., 13, 247.
40. PHILLIPS, C., STRAUSS, H.J., WORTZEL, R.D. & SCHREIBER, A. (1986). Novel MHC class I molecule as a tumour-specific antigen: correlation between the antibody defined and the CTL defined target structure. Immunogenetics, 13, 93.
41. PLOEGH, H.L., ORR, H.T. & STROMINGER, J.L. (1981). Major histocompatibility antigens: the human (HLA A, B, C) and murine (H-2K, H-2D) class I molecules. Cell, 24, 287.
42. ROGERS, M.J., GQDING, L.R., MAGULIES, D.H. & EVANS, G.A. (1983). Analysis of a defect in the H-2 genes of SV40 transformed C3H fibroblast that do not express H-2K. J. Immunol., 130, 2418.
43. RUIZ-CABELLO, F., LÓPEZ-NEVOT, M. A. & GARRIDO, F. (1987). MHC class I and II gene expression on human tumours. International Meeting on Cancer Metastases, Bologna.
44. SCHIRMACHER, V., ROBINSON, P., ALTEVOGT, P. & 5 others (1981). Clonal analysis of H-2 antigen expression by variants of a chemically induced murine tumour. Transplant. Proc., 13, 1819.
45. SMITH, M.E.F., BODMER, W.F. & BODMER, J.G. (1988). Selective loss of HLA-A, B, C locus products in colorectal adenocarcinoma. Lancet, i, 823.
46. SOOD, A.K., PEREIRA, D. & WEISSMAN, S.M. (1981). Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligonucleotide primer. Proc. Natl Acad. Sci. USA, 78, 616.
47. SOUTHERN, E.M. (1975). Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98, 503.
48. TERASAKI, P.I. & MCCLELLAND, J.D. (1964). A microdroplet assay of human serum cytotoxicity. Nature, 204, 998.
49. ZINKERNAGEL, R.M. & DOHERTY, P.C. (1974). Restriction of in vitro T-cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic semiallogeneic system. Nature, 248, 701.